These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2650537)

  • 1. Renal vascular and thrombotic effects of cyclosporine.
    Remuzzi G; Bertani T
    Am J Kidney Dis; 1989 Apr; 13(4):261-72. PubMed ID: 2650537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal injury induced by long-term administration of cyclosporin A to rats.
    Bertani T; Perico N; Abbate M; Battaglia C; Remuzzi G
    Am J Pathol; 1987 Jun; 127(3):569-79. PubMed ID: 3591904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thromboxane receptor blockade attenuates the toxic effect of cyclosporine in experimental renal transplantation.
    Rossini M; Belloni A; Remuzzi G; Perico N
    Circulation; 1990 Jan; 81(1 Suppl):I61-7; discussion I68. PubMed ID: 2136819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of short-term cyclosporine administration in rats on renin-angiotensin and thromboxane A2: possible relevance to the reduction in glomerular filtration rate.
    Perico N; Zoja C; Benigni A; Ghilardi F; Gualandris L; Remuzzi G
    J Pharmacol Exp Ther; 1986 Oct; 239(1):229-35. PubMed ID: 3531461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thromboxane receptor blockade improves cyclosporine nephrotoxicity in rats.
    Spurney RF; Mayros SD; Collins D; Ruiz P; Klotman PE; Coffman T
    Prostaglandins; 1990 Feb; 39(2):135-46. PubMed ID: 2138344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporin reduces renal blood flow through vasoconstriction of arcuate arteries in the hydronephrotic rat model.
    Zimmerhackl LB; Fretschner M; Steinhausen M
    Klin Wochenschr; 1990 Feb; 68(3):166-74. PubMed ID: 2314004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-induced nephrotoxicity. Aetiology, clinical features and management.
    Hoitsma AJ; Wetzels JF; Koene RA
    Drug Saf; 1991; 6(2):131-47. PubMed ID: 2043284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nephrotoxicity of cyclosporin A in humans: effects on glomerular filtration and tubular reabsorption rates.
    Dieperink H; Leyssac PP; Kemp E; Starklint H; Frandsen NE; Tvede N; Møller J; Buchler Frederiksen P; Rossing N
    Eur J Clin Invest; 1987 Dec; 17(6):493-6. PubMed ID: 3123248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nephrotoxicity of cyclosporine A in rats with a diminished renal function.
    Provoost AP; Kaptein L; Van Aken M
    Clin Nephrol; 1986; 25 Suppl 1():S162-7. PubMed ID: 3519023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased urinary excretion of thromboxane B2 and 2,3-dinor-TxB2 in cyclosporin A nephrotoxicity.
    Benigni A; Chiabrando C; Piccinelli A; Perico N; Gavinelli M; Furci L; Patino O; Abbate M; Bertani T; Remuzzi G
    Kidney Int; 1988 Aug; 34(2):164-74. PubMed ID: 3184595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The beneficial effect of atrial natriuretic peptide on cyclosporine nephrotoxicity.
    Capasso G; Rosati C; Ciani F; Giordano DR; Russo F; De Santo NG
    Am J Hypertens; 1990 Mar; 3(3):204-10. PubMed ID: 2138899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A trial of the prostaglandin E1 analogue, enisoprost, to reverse chronic cyclosporine-associated renal dysfunction.
    Pollak R; Knight R; Mozes MF; Maddux M; Veremis S; Van Buren C; Lewis R; Scott E; Cole M; Hyndman V
    Am J Kidney Dis; 1992 Oct; 20(4):336-41. PubMed ID: 1415200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporine-induced acute renal dysfunction in the rat. Evidence of arteriolar vasoconstriction with preservation of tubular function.
    English J; Evan A; Houghton DC; Bennett WM
    Transplantation; 1987 Jul; 44(1):135-41. PubMed ID: 3603674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of late onset cyclosporine-induced hemolytic uremic syndrome resulting in renal graft loss.
    Katafuchi R; Saito S; Ikeda K; Hirano T; Yanase T; Nakashima K; Fujimi S
    Clin Transplant; 1999; 13 Suppl 1():54-8. PubMed ID: 10751058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal function after 10 years' treatment with cyclosporin for psoriasis.
    Powles AV; Hardman CM; Porter WM; Cook T; Hulme B; Fry L
    Br J Dermatol; 1998 Mar; 138(3):443-9. PubMed ID: 9580797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporine A nephrotoxicity: role of thromboxane and reactive oxygen species.
    Parra T; de Arriba G; Arribas I; Perez de Lema G; Rodriguez-Puyol D; Rodriguez-Puyol M
    J Lab Clin Med; 1998 Jan; 131(1):63-70. PubMed ID: 9452128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained renal function loss in psoriasis patients after withdrawal of low-dose cyclosporin therapy.
    Korstanje MJ; Bilo HJ; Stoof TJ
    Br J Dermatol; 1992 Nov; 127(5):501-4. PubMed ID: 1467290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional significance of exaggerated renal thromboxane A2 synthesis induced by cyclosporin A.
    Perico N; Benigni A; Zoja C; Delaini F; Remuzzi G
    Am J Physiol; 1986 Oct; 251(4 Pt 2):F581-7. PubMed ID: 3094383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical analysis of renin activity in chronic cyclosporine nephropathy in childhood nephrotic syndrome.
    Iijima K; Hamahira K; Kobayashi A; Nakamura H; Yoshikawa N
    J Am Soc Nephrol; 2000 Dec; 11(12):2265-2271. PubMed ID: 11095649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of cyclosporine A on adaptive hypertrophy after unilateral nephrectomy in the rat.
    Schurek HJ; Neumann KH; Jesinghaus WP; Aeikens B; Wonigeit K
    Clin Nephrol; 1986; 25 Suppl 1():S144-7. PubMed ID: 3708925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.